Alternatives to Cibinqo If You Can't Fill Your Prescription

Cibinqo (abrocitinib) is a powerful oral treatment for moderate-to-severe atopic dermatitis (eczema) — but insurance barriers, prior authorization delays, cost, and specialty pharmacy access can leave patients without their medication for weeks. If you're in that situation, it's important to know your options. Several effective alternatives are available, and your dermatologist can help you determine which one fits your situation best.

Why Patients May Need an Alternative to Cibinqo

Common reasons patients switch away from or can't access Cibinqo include:

Insurance denial or prior authorization delay

Cost: retail price of ~$7,000/month with no generic available

Side effects that make Cibinqo intolerable (nausea, infections, thrombocytopenia)

Contraindications: pregnancy, active serious infection, antiplatelet therapy use

Inadequate response: some patients don't achieve sufficient clearance on abrocitinib

Alternative #1: Dupixent (Dupilumab) — The Most Common First-Line Biologic

Dupixent (dupilumab) is a biologic medication manufactured by Sanofi/Regeneron. It's a subcutaneous injection (under the skin) given every 2 weeks after an initial loading dose. Dupixent blocks both IL-4 and IL-13 — two key cytokines that drive atopic dermatitis inflammation.

Key differences from Cibinqo:

No boxed warning — unlike Cibinqo's JAK inhibitor class warning for infections, blood clots, and malignancy

Injection rather than oral pill — may be less convenient for some patients

Approved for ages 6 months and older — broader pediatric coverage than Cibinqo (12+)

Also approved for asthma, nasal polyps, eosinophilic esophagitis — multiple indications

Dupixent is often the first biologic tried before Cibinqo is approved. If you can't get Cibinqo, Dupixent may actually be more accessible on your formulary.

Alternative #2: Rinvoq (Upadacitinib) — The Oral Rival

Rinvoq (upadacitinib), made by AbbVie, is also an oral once-daily JAK1 inhibitor approved for moderate-to-severe atopic dermatitis in adults and adolescents 12 and older. It's the most direct competitor to Cibinqo in the same drug class.

Key comparisons:

Head-to-head data shows Rinvoq 30 mg may achieve higher skin clearance rates than dupilumab in some patients

Carries the same JAK inhibitor boxed warning as Cibinqo (infections, malignancy, thrombosis)

Available in 15 mg and 30 mg doses; Cibinqo is available in 100 mg and 200 mg

May be covered on different formulary tiers than Cibinqo — check your specific plan

Alternative #3: Adbry (Tralokinumab) — An Injectable IL-13 Inhibitor

Adbry (tralokinumab) is a biologic made by LEO Pharma, approved for moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older. Unlike Dupixent, it targets only IL-13 (not IL-4). It's given as a subcutaneous injection every 2 weeks initially, with the option to reduce to once monthly after adequate response at 16 weeks.

Key features:

No boxed warning — safe profile without JAK-inhibitor-class risks

Monthly maintenance dosing possible — convenient for long-term management

Has shown efficacy in some patients who didn't respond to dupilumab

37,512+ patients found their medications in stock

37K+

Find Cibinqo In Stock Today →

Alternative #4: Ebglyss (Lebrikizumab) — Newer IL-13 Biologic

Ebglyss (lebrikizumab) by Eli Lilly is another IL-13 inhibitor biologic approved for moderate-to-severe atopic dermatitis in patients 12 and older. It offers monthly maintenance dosing after an initial induction period, and carries no boxed warning. Some patients who don't respond well to Dupixent may respond to lebrikizumab.

How to Choose the Right Alternative

The best alternative for you depends on several factors:

Your reason for not being able to get Cibinqo (cost vs. PA denial vs. side effects)

Your preference for oral pills vs. injections

Your risk factors (infection history, cardiovascular risk, planned pregnancy)

What your insurance covers and at what tier

Don't give up on Cibinqo just yet. Before switching, read our guide on how to find Cibinqo in stock near you — there may be options you haven't explored yet.

Skip the calls, skip the stress.

Find Cibinqo In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

medfinder Can Help You Find Whichever Medication You Need

Whether you need Cibinqo or an alternative like Rinvoq, Dupixent, Adbry, or Ebglyss, medfinder calls pharmacies near you to check availability. medfinder covers all medications — not just Cibinqo. Just provide your medication, dose, and location, and we'll text you results.